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Progressive Apraxia of Speech:  Might There Be Subtypes? 
 
ABSTRACT 
This study examined speech and language characteristics of three groups of individuals with 
neurodegenerative disease: (1) primary progressive apraxia of speech (AOS) without aphasia 
(N=18), (2) agrammatic primary progressive aphasia (agPPA) less severe than AOS (N=10), and 
(3) agPPA more severe than AOS (N=9).  Findings indicate that differences in the predominant 
characteristics of AOS (predominance of articulatory versus prosodic abnormalities) distributed 
differently among the three groups, independent of AOS severity.  Neuroimaging findings also 
differed among the groups.  Results suggest that neurodegenerative AOS may include 
perceptually distinguishable subtypes that are related to the presence or absence of aphasia and 
neuroimaging findings.        
 
Proposal (word count, excluding Refs & Tables = 1,190) 
Primary progressive aphasia (PPA) has been recognized as an identifiable clinical entity for 
several decades, and a large body of research has examined its clinical characteristics, 
neuroimaging correlates, and underlying pathology (e.g., Mesulam, 1982; Gorno-Tempini et al., 
2011).  More recently, it has been recognized that apraxia of speech (AOS) can also be 
associated with neurodegenerative disease (e.g., Duffy, 2006; Josephs et al., 2012), an entity that 
has been called progressive AOS (PAOS).  PAOS is often accompanied by aphasia but it can be 
more prominent than any aphasia and sometimes occurs without aphasia or any other neurologic 
signs or symptoms, in which case it has been called primary progressive AOS (PPAOS) (Duffy 
& Josephs, 2012; Duffy & McNeil, 2008; Josephs et al., 2012).  The separation of PAOS from 
PPA is obviously important clinically, but also important because data suggest they are not 
identical in their localization and may have different underlying pathologies (e.g., (Deramecourt 
et al., 2010, Josephs et al., 2006). 
During a large ongoing study of people with PPA and PAOS we have observed that a 
substantial proportion of those with AOS and PPA with agrammatic language characteristics are 
difficult to classify; they do not meet criteria for PPAOS because they have aphasia, and they do 
not meet criteria for the agrammatic variant of PPA (agPPA) (Gorno-Tempini et al., 2011) 
because the dominant debilitating feature of the syndrome is AOS (i.e., AOS>aphasia). We have 
also noted different patterns of motor speech difficulty among those with PPAOS, AOS>aphasia, 
and agPPA.  Some have articulatory distortions and distorted sound substitutions as the 
predominant AOS characteristics, whereas others’ AOS is predominated by slowly produced, 
syllabically segmented speech with less prominent articulatory distortions and sound 
substitutions.  These different patterns raise the possibility that they might be differentially 
associated with different clinical syndrome identities (i.e., PPAOS, AOS>aphasia, agPPA). 
The purpose of this study was to examine the relationships among the clinical syndromes 
of PPAOS, AOS>aphasia, and agPPA, and to determine whether differing predominant AOS 
characteristics were differentially associated with the three clinical syndromes and their 
neuroimaging correlates.  We hypothesized that the clinical syndromes would have 
distinguishable neuroimaging characteristics and that different patterns of AOS speech 
characteristics (AOS subtypes) would distribute differently among the clinical syndromes.  
Methods  
Thirty-seven subjects (Ss) with PAOS and/or aphasia participated in this study.  Eighteen had 
PPAOS without evidence of aphasia, ten had PAOS judged to be more prominent than 
accompanying aphasia (AOS>aphasia), and nine met criteria for the agrammatic variant of PPA 
(agPPA) (Gorno-Tempini et al., 2011), in which the aphasia was more prominent than any 
accompanying AOS.  Good interjudge reliability was achieved for these groupings.  All Ss had 
identical imaging sequences: volumetric head MRI, diffusion tensor imaging, f18-
fleurodeoxyglucose and C11 labeled Pittsburg compound B PET scanning.  
Speech-language assessment included the Western Aphasia Battery (WAB-R; Kertesz, 
2007), Part 1; several reading and writing subtests from the WAB-R, Part 2; several word 
fluency tasks (Loonstra, Tarlow, & Sellars, 2001; Woods et al., 2005); a 15-item Boston Naming 
Test (Lansing et al., 1999); Token Test, Part V (Wertz, Keith, & Custer, 1971); and a protocol 
we designed to elicit additional speech responses to help further characterize motor speech 
deficits.  Ss also underwent neurologic and neuropsychological assessments but those results will 
be addressed only briefly in this presentation.  
The diagnosis of AOS was based on the independent judgment of two speech-language 
pathologists blinded to neuroimaging, clinical neurology, and neuropsychology test results.  
Agreement about the presence versus absence of AOS was 100%. AOS severity was rated on a 
0-4 scale (4=severe) and was also indexed by an AOS rating scale (ASRS) that rates each of 16 
speech features that can be associated with AOS on a 5-point scale (0=not present; 4=nearly 
always present and markedly severe).   
Regarding AOS subtypes, a designation of AOS Type 1 was made if distorted sound 
substitutions or additions (often increasing with increased utterance length or complexity) were 
judged to clearly dominate the speech pattern.  A designation of AOS Type 2 was made if 
syllable segmentation within multisyllabic words or across words in phrases, and lengthened 
intersegment durations between syllables, words or phrases, was judged to clearly dominate the 
speech pattern.  If there was no clear predominance of Type 1 or Type 2 features, a designation 
of AOS NOS (not otherwise specified) was made.  Interjudge agreement about AOS subtype for 
the 36 subjects judged to have AOS was 94% (34/36); the remaining two Ss were ultimately 
classified by consensus as AOS NOS.  AOS presence and type was declared at consensus 
meetings, independent of the classification of Ss as to PPA presence and type.  Agreement about 
PPA type (i.e., agPPA) was 100%.  Other PPA variants were not included in this study.   
The presence or absence of dysarthria and its type was rated on a 0-4 severity scale.  
Consensus about dysarthria presence, type and severity and presence and severity of nonverbal 
oral apraxia was reached at consensus meetings.  
Results  
Basic demographic data are summarized in Table 1.  Clinical and neuroimaging data are 
summarized and synthesized in Tables 2 and 3.  Composite neuroimaging images will be shown 
during the presentation and samples of AOS subtype will be played.   
The findings to be emphasized in this presentation are summarized as follows:    
1. The AOS>aphasia group had more severe AOS than the PPAOS and agPPA 
groups, but less severe aphasia than the agPPA group.  
2. AOS severity in PPAOS and agPPA were similar.  
3. Ss with PPAOS and AOS>aphasia most often had AOS Type 2, while those with 
agPPA mainly had AOS Type 1.  
4. Neuroimaging abnormalities were observed predominantly in the left hemisphere 
in all three groups.  Both PPAOS and AOS>aphasia had changes in superior 
premotor cortex, but those with AOS>aphasia also had abnormalities in inferior 
premotor cortex.  The agPPA group showed widespread involvement affecting 
premotor, prefrontal, temporal, parietal, caudate, and insula areas.  
5. The results suggest that both PPAOS and AOS>aphasia are distinct from agPPA.  
They suggest that Ss with AOS>aphasia may have more advanced disease than 
those with PPAOS.  
The finding that will be emphasized is the identification of what may be two clinically 
distinguishable subtypes of progressive AOS.  It suggests that the two primary deficits in broad 
characterizations of AOS - articulation and prosody - can be relatively, although not completely 
dissociated in some cases, at least in neurodegenerative PAOS.  Severity differences probably 
cannot explain the subtype distinction because AOS severity ratings did not differ between the 
agPPA group (with Type 1 predominance) and the PPAOS group (with Type 2 predominance).  
The underlying explanation for the subtype differences are not clear but, because motor speech 
programming probably involves several stages (more than a single process) that are 
accomplished within a complex functional anatomic network (more than a single brain location), 
it is reasonable to hypothesize that subtypes of AOS, manifest as a predominance of some 
abnormal features over others, might become evident as a function of differential impairment of 
one or more programming steps that occur in different anatomic locations in the speech-language 
network.  This has implications for our understanding of AOS in general, regardless of its 
etiology.  Further study is obviously required to replicate these findings and identify the relevant 
explanatory variables.          
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     Table 1: Summary of demographic and neurological data 
 PPAOS AOS>aphasia agPPA p value 
N 18 10 9  
Demographics 
    

Female (%) 13 (72%) 1 (10%) 5 (56%) 0.007 
    Handedness 
(R/L/Ambidex.) 16/1/1 9/1/0 8/1/0 0.85 
    Disease duration 
(yrs.) 3.0 (2.0-4.4) 3.8 (2.5 - 4.8) 2.5 (1.5 - 3.5) 0.20 
    Age at onset 72.0 (61.5-76.3) 69 (63.8 - 74.0) 66 (59 - 70) 0.27 
    Age at time of 
examination 
 
74.5 (66.0-79.0) 73.5 (67.0 - 77.0) 70 (62.5 - 71.5) 0.14 
    Education (yrs.) 15.0 (12.8-17.1) 13 (12 - 17.3) 16 (12.5 - 17) 0.58 

Significance achieved comparing PPAOS and AOS>aphasia 

Significance achieved comparing AOS>aphasia and agPPA 
 
Table 2: Summary of speech, language and oral praxis data  
 PPAOS AOS>aphasia agPPA p value 
N 18 10 9  
WAB     

AQ (/100) 96.9 (95.8-99.0) 85.5 (82.1 - 95.3) 84.1 (64.7 - 89.6) 
     
<0.0001 

Spontaneous 
speech (/20) 20 (19-20) 16 (14 - 19) 15.0 (12.5 - 16.0) <0.0001 
β
Aud. Verbal 
comp (/10) 10 (9.8-10.0) 10 (9.5 - 10) 9.3 (9.2 - 9.7) 0.0008 
β
Repetition (/10) 9.7 (9.4-9.9) 9.2 (8.2 - 9.7) 8.8 (4.6 - 9.6) 0.01 
β
Naming/word 
finding (/10) 9.6 (9.3-10.0) 9.1 (8.4 - 9.4) 8.8 (7.1 - 9.0) <0.0001 
β
WAB writing 
output (/34) 34 (32.8-34.0) 23.3 (17.5 - 31.3) 24.0 (12.3 - 31.5) 0.0004 
β
Token Test 
part 5 (/22; 
22=best) 21 (19-22) 18.0 (14.0 - 19.0) 12.0 (4.5 - 17.5) <0.0001 
β
Action 
Fluency  12 (10.8-16.0) 8.0 (6.5 - 9.0) 6.0 (3 - 10.5) 0.009 
β
Letter fluency 23.5 (14.3-33.3) 19.0 (12.0 - 22.5) 10.0 (7 - 13.5) 0.01 
β
Boston Naming 
Test (/15) 14 (13-15) 13 (12.8 - 15.0) 12 (6 - 14.5) 0.04 
AOS     

ASRS total 
score (/64; 
0=best) 17.5 (12.8-20.3) 30.5 (21 - 38.3) 13 (6 - 23.5) 0.003 

Number of 
abnormal 
features (/16) 10.5 (9.0-13.0) 13 (11 - 14.5) 11 (6 - 12) 0.03 

AOS severity             
None 0 0 1 (11%) 
0.01 
Mild 10 (55.6%) 1 (10%) 5 (56%) 
Moderate 7 (38.9%) 3 (30%) 1 (11%) 
Marked 1 (5.6%) 4 (40%) 0 
Severe 0 2 (20%) 2 (22%) 

AOS type     
Type 1 4 (22%) 2 (20%) 5 (63%) 
0.01 
Type 2 13 (72%) 5 (50%) 0 (0%) 
NOS 1 (6%) 3 (30%) 3 (37%) 
Dysarthria      
None 13 (72%) 5 (50%) 8 (89%) 
0.17 
Spastic 5 (28%)*† 5 (50%) 1 (11%) 
Severity rating 
(0-4) 0 (0-1) 0.75 (0 - 4) 0 (0 - 0) 0.08 
β
Non-verbal 
Oral Apraxia 
 
   
None 9 (50%) 1 (10%) 0 (0%) 
0.004 
Mild 3 (16.7%) 1 (10%) 6 (67%) 
Moderate 2 (11.1%) 5 (50%) 1 (11%) 
Marked 3 (16.7%) 2 (20%) 0 (0%) 
Severe 1 (5.6%) 1 (10%) 2(22%)  
Score (/32; 
32=normal) 30 (17.8-32.0) 21.5 (14.8 - 26.8) 28 (15 - 29.5) 0.12 
Data shown as median (inter-quartile range) or number (%) 
* One case also had questionable hypokinetic dysarthria 
† One case has spastic dysarthria versus spasmodic dysphonia 
‡ One case had questionable hyperkinetic dysarthria and another had strained voice only 
P values across all three groups calculated using Kruskal-Wallis test for continuous variables and 
chi-square for categorical variables 

Significance achieved comparing PPAOS and AOS>aphasia 

Significance achieved comparing PPAOS and agPPA 

Significance achieved comparing AOS>aphasia and agPPA 
 
     Table 3: Global summary of important characteristic differences across groups. 
 PPAOS AOS>aphasia agPPA 
Speech & language 
Apraxia of speech + + +/- 
Predominant AOS type 2 2 1 
Agrammatic aphasia  - + + 
Spastic dysarthria +/- +/- +/- 
Non-verbal oral apraxia +/- +/- + 
Neuroimaging* 
Cortical 
Prefrontal - - + 
Superior premotor  + + + 
Inferior premotor  - + + 
Medial temporal - - + 
Lateral temporoparietal - - + 
Left frontotemporoparietal  - - + 
Subcortical 
Caudate - + + 
Lentiform - - - 
Thalamus - - - 
Brainstem/cerebellum 
Midbrain  + + - 
Cerebellar white matter - + - 
             * Cortical regions are limited to those in left hemisphere 
 + = abnormality present, - = absent, +/- = can be present or absent 
 
